Why the study?
Diagnosis of von Willebrand disease is difficult and complex because no single test explores all von Willebrand factor activities to confirm or exclude diagnosis.
What are the recent advances in the laboratory diagnosis and classification of von Willebrand disease?
What are the recent advances in the laboratory diagnosis and classification of von Willebrand disease?
Novel automated assays and the VWF-collagen binding assay improve the complex laboratory diagnosis and classification of von Willebrand disease, particularly for type 2 variants.
Answers are grounded in this paper and cite their sources.
Advances in VWF assays may refine VWD diagnosis; leaves open standardization and prospective validation before routine use.
Introduction: The diagnosis of von Willebrand disease (VWD) may be difficult and is based on the assessment of bleeding history and several diagnostic assays, which evaluate the pleiotropic function of von Willebrand factor (VWF). Laboratory diagnosis requires a series of assays to determine VWF concentration and function, and factor VIII activity, but no single test is available to explore all VWF activities to confirm or exclude diagnosis.Areas covered: This review describes the advances in diagnosing VWD, starting from how to define and quantify the bleeding history to the new assays exploring VWF activities.Expert opinion: VWD is the most common inherited bleeding disorder, is highly heterogeneous, and its appropriate diagnosis may represent a complex laboratory task, especially for type 2 variants. Until recently, the ristocetin cofactor activity assay has represented the standard method for measuring VWF activity, as its ability to bind to platelets in presence of ristocetin, but it has low sensitivity and high variability of results. Novel assays are increasingly used, are often automated and correlate excellently with the standard assay but sometimes discrepant results may lead to a different classification of VWD. The VWF-collagen binding assay is a useful complementary assay to better categorize type 2 variants.
No takes yet. Share an insight, caveat, or question.
Castaman et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: